Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 2,914 | $0.00 Strike: $7.88 | $0.00 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · derivative · entry 14 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,914 shares Expires 2029-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 647 | $0.00 Strike: $8.93 | $0.00 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · derivative · entry 13 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 647 shares Expires 2028-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
SaleCommon Stock | 647 | $25.07 | $16,220.74 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 4 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 102,899 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $25.00 to $25.215. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionCommon Stock | 647 | $8.93 | $5,777.71 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 3 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
SaleCommon Stock | 2,914 | $25.07 | $73,056.02 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 2 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 102,899 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $25.00 to $25.215. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:49 UTC |
Katkin KeithDirector
|
Exercise / conversionCommon Stock | 2,914 | $7.88 | $22,962.32 |
DisclosureSEC source: 0001562180-22-007011 · primarydocument.xml · nonDerivative · entry 1 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 29,606 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001562180-22-007012 · primarydocument.xml · derivative · entry 7 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,606 shares Expires 2027-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
SaleCommon Stock | 29,606 | $25.02 | $740,756.92 |
DisclosureSEC source: 0001562180-22-007012 · primarydocument.xml · nonDerivative · entry 2 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,659 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 690,759 options to purchase shares of common stock that are vested and immediately exercisable and a total of 485,001 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $25.00 to $25.15. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:49 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 29,606 | $8.77 | $259,644.62 |
DisclosureSEC source: 0001562180-22-007012 · primarydocument.xml · nonDerivative · entry 1 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,265 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 20:18 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionStock Options (Right to buy) · Derivative | 59,649 | $0.00 Strike: $10.90 | $0.00 |
DisclosureSEC source: 0001562180-22-006788 · primarydocument.xml · derivative · entry 6 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,649 shares Expires 2025-09-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 20:18 UTC |
Morrison BriggsDirector · President, Head of R&D
|
SaleCommon Stock | 59,649 | $23.25 | $1,387,012.23 |
DisclosureSEC source: 0001562180-22-006788 · primarydocument.xml · nonDerivative · entry 4 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,836 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 774,958 options to purchase shares of common stock that are vested and immediately exercisable and a total of 370,042 options to purchase shares of common stock that have not yet vested. F3 · price: The sale prices ranged from $22.60 to $23.75 Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 20:18 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionCommon Stock | 59,649 | $10.90 | $650,174.10 |
DisclosureSEC source: 0001562180-22-006788 · primarydocument.xml · nonDerivative · entry 3 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 20:18 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionStock Options (Right to buy) · Derivative | 114,339 | $0.00 Strike: $10.90 | $0.00 |
DisclosureSEC source: 0001562180-22-006788 · primarydocument.xml · derivative · entry 5 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 114,339 shares Expires 2025-09-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 20:18 UTC |
Morrison BriggsDirector · President, Head of R&D
|
SaleCommon Stock | 114,339 | $23.03 | $2,633,044.23 |
DisclosureSEC source: 0001562180-22-006788 · primarydocument.xml · nonDerivative · entry 2 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,836 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 774,958 options to purchase shares of common stock that are vested and immediately exercisable and a total of 370,042 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $22.50 to $23.35 Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 20:18 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionCommon Stock | 114,339 | $10.90 | $1,246,295.10 |
DisclosureSEC source: 0001562180-22-006788 · primarydocument.xml · nonDerivative · entry 1 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 17:34 UTC |
Podlesak DennisDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 5,419 | $0.00 Strike: $6.32 | $0.00 |
DisclosureSEC source: 0001562180-22-006705 · primarydocument.xml · derivative · entry 9 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,419 shares Expires 2024-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 17:34 UTC |
Podlesak DennisDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 6,556 | $0.00 Strike: $6.35 | $0.00 |
DisclosureSEC source: 0001562180-22-006705 · primarydocument.xml · derivative · entry 8 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,556 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 17:34 UTC |
Podlesak DennisDirector
|
SaleCommon Stock | 6,556 | $23.43 | $153,624.78 |
DisclosureSEC source: 0001562180-22-006705 · primarydocument.xml · nonDerivative · entry 6 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,763 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 192,600 options to purchase shares of common stock that are vested and immediately exercisable and no unvested options to purchase shares of common stock. F3 · price: The sale prices ranged from $22.96 to $24.07 Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 17:34 UTC |
Podlesak DennisDirector
|
Exercise / conversionCommon Stock | 6,556 | $6.35 | $41,630.60 |
DisclosureSEC source: 0001562180-22-006705 · primarydocument.xml · nonDerivative · entry 5 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 17:34 UTC |
Podlesak DennisDirector
|
SaleCommon Stock | 5,419 | $23.43 | $126,981.80 |
DisclosureSEC source: 0001562180-22-006705 · primarydocument.xml · nonDerivative · entry 4 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,763 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 192,600 options to purchase shares of common stock that are vested and immediately exercisable and no unvested options to purchase shares of common stock. F3 · price: The sale prices ranged from $22.96 to $24.07 Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 17:34 UTC |
Podlesak DennisDirector
|
Exercise / conversionCommon Stock | 5,419 | $6.32 | $34,248.08 |
DisclosureSEC source: 0001562180-22-006705 · primarydocument.xml · nonDerivative · entry 3 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionStock Options (Right to buy) · Derivative | 71,966 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · derivative · entry 12 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71,966 shares Expires 2025-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionStock Options (Right to buy) · Derivative | 53,034 | $0.00 Strike: $10.90 | $0.00 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · derivative · entry 11 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,034 shares Expires 2025-09-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
SaleCommon Stock | 53,034 | $23.22 | $1,231,422.96 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · nonDerivative · entry 8 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,836 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 948,946 options to purchase shares of common stock that are vested and immediately exercisable and a total of 245,042 options to purchase shares of common stock that have not yet vested. F4 · price: The sale prices ranged from $22.96 to $23.99 Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionCommon Stock | 53,034 | $10.90 | $578,070.60 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · nonDerivative · entry 7 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
SaleCommon Stock | 71,966 | $23.22 | $1,671,014.54 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · nonDerivative · entry 6 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,836 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 948,946 options to purchase shares of common stock that are vested and immediately exercisable and a total of 245,042 options to purchase shares of common stock that have not yet vested. F4 · price: The sale prices ranged from $22.96 to $23.99 Read SEC document |
| September 16, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionCommon Stock | 71,966 | $7.20 | $518,155.20 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · nonDerivative · entry 5 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 17:34 UTC |
Podlesak DennisDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 66,840 | $0.00 Strike: $6.32 | $0.00 |
DisclosureSEC source: 0001562180-22-006705 · primarydocument.xml · derivative · entry 7 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 66,840 shares Expires 2024-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 17:34 UTC |
Podlesak DennisDirector
|
SaleCommon Stock | 66,840 | $24.20 | $1,617,380.95 |
DisclosureSEC source: 0001562180-22-006705 · primarydocument.xml · nonDerivative · entry 2 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,763 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 192,600 options to purchase shares of common stock that are vested and immediately exercisable and no unvested options to purchase shares of common stock. F2 · price: The sale prices ranged from $23.37 to $24.64 Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 17:34 UTC |
Podlesak DennisDirector
|
Exercise / conversionCommon Stock | 66,840 | $6.32 | $422,428.80 |
DisclosureSEC source: 0001562180-22-006705 · primarydocument.xml · nonDerivative · entry 1 Podlesak Dennis · CIK 0001314595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionStock Options (Right to buy) · Derivative | 66,775 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · derivative · entry 10 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 66,775 shares Expires 2025-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
SaleCommon Stock | 66,775 | $24.20 | $1,616,035.13 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · nonDerivative · entry 4 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,836 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 948,946 options to purchase shares of common stock that are vested and immediately exercisable and a total of 245,042 options to purchase shares of common stock that have not yet vested. F3 · price: The sale prices ranged from $23.36 to $24.64 Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionCommon Stock | 66,775 | $7.20 | $480,780.00 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · nonDerivative · entry 3 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionStock Options (Right to buy) · Derivative | 87,645 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · derivative · entry 9 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,645 shares Expires 2025-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
SaleCommon Stock | 87,645 | $23.80 | $2,085,854.59 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · nonDerivative · entry 2 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,836 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 948,946 options to purchase shares of common stock that are vested and immediately exercisable and a total of 245,042 options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $23.36 to $24.01 Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 21:34 UTC |
Morrison BriggsDirector · President, Head of R&D
|
Exercise / conversionCommon Stock | 87,645 | $7.20 | $631,044.00 |
DisclosureSEC source: 0001562180-22-006706 · primarydocument.xml · nonDerivative · entry 1 Morrison Briggs · CIK 0001654430 · Director · President, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:14 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 22,846 | $0.00 Strike: $6.32 | $0.00 |
DisclosureSEC source: 0001562180-22-006334 · primarydocument.xml · derivative · entry 7 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,846 shares Expires 2024-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:14 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 2,154 | $0.00 Strike: $6.35 | $0.00 |
DisclosureSEC source: 0001562180-22-006334 · primarydocument.xml · derivative · entry 6 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,154 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:14 UTC |
Ordentlich PeterChief Scientific Officer
|
SaleCommon Stock | 2,154 | $25.04 | $53,926.90 |
DisclosureSEC source: 0001562180-22-006334 · primarydocument.xml · nonDerivative · entry 5 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 255,647 options to purchase shares of common stock that are vested and immediately exercisable and a total of 148,194 options to purchase shares of common stock that have not yet vested. F3 · price: The sale prices ranged from $25.00 to $25.18. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:14 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionCommon Stock | 2,154 | $6.35 | $13,677.90 |
DisclosureSEC source: 0001562180-22-006334 · primarydocument.xml · nonDerivative · entry 4 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:14 UTC |
Ordentlich PeterChief Scientific Officer
|
SaleCommon Stock | 22,846 | $25.04 | $571,965.60 |
DisclosureSEC source: 0001562180-22-006334 · primarydocument.xml · nonDerivative · entry 3 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 255,647 options to purchase shares of common stock that are vested and immediately exercisable and a total of 148,194 options to purchase shares of common stock that have not yet vested. F3 · price: The sale prices ranged from $25.00 to $25.18. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:14 UTC |
Ordentlich PeterChief Scientific Officer
|
Exercise / conversionCommon Stock | 22,846 | $6.32 | $144,386.72 |
DisclosureSEC source: 0001562180-22-006334 · primarydocument.xml · nonDerivative · entry 2 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 16:05 UTC |
Legault PierreDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 14,000 | $0.00 Strike: $8.93 | $0.00 |
DisclosureSEC source: 0001562180-22-005979 · primarydocument.xml · derivative · entry 6 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2028-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 16:05 UTC |
Legault PierreDirector
|
Exercise / conversionStock Options (Right to buy) · Derivative | 10,000 | $0.00 Strike: $9.63 | $0.00 |
DisclosureSEC source: 0001562180-22-005979 · primarydocument.xml · derivative · entry 5 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2028-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 16:05 UTC |
Legault PierreDirector
|
SaleCommon Stock | 14,000 | $23.02 | $322,222.60 |
DisclosureSEC source: 0001562180-22-005979 · primarydocument.xml · nonDerivative · entry 4 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 39,000 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $23.00 to $23.12 Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 16:05 UTC |
Legault PierreDirector
|
Exercise / conversionCommon Stock | 14,000 | $8.93 | $125,020.00 |
DisclosureSEC source: 0001562180-22-005979 · primarydocument.xml · nonDerivative · entry 3 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 16:05 UTC |
Legault PierreDirector
|
SaleCommon Stock | 10,000 | $23.02 | $230,159.00 |
DisclosureSEC source: 0001562180-22-005979 · primarydocument.xml · nonDerivative · entry 2 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 39,000 options to purchase shares of common stock that are vested and immediately exercisable and there are no options to purchase shares of common stock that have not yet vested. F2 · price: The sale prices ranged from $23.00 to $23.12 Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 16:05 UTC |
Legault PierreDirector
|
Exercise / conversionCommon Stock | 10,000 | $9.63 | $96,300.00 |
DisclosureSEC source: 0001562180-22-005979 · primarydocument.xml · nonDerivative · entry 1 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2022 Filed Aug 26, 2022 20:14 UTC |
Ordentlich PeterChief Scientific Officer
|
OtherCommon Stock | 265 | $14.12 | $3,741.80 |
DisclosureSEC source: 0001562180-22-006334 · primarydocument.xml · nonDerivative · entry 1 Ordentlich Peter · CIK 0001594274 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265 F1 · kind: The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 265 shares by the Reporting Person on 07/29/2022 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 25, 2022 Filed Jul 27, 2022 22:42 UTC |
Metzger Michael ADirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 11,838 | $0.00 Strike: $6.38 | $0.00 |
DisclosureSEC source: 0001562180-22-005761 · primarydocument.xml · derivative · entry 6 Metzger Michael A · CIK 0001507220 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,838 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests periodically upon the Issuer achieving certain milestones. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.